| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 75% | 9/12 |
| Female | 25% | 3/12 |
| Indifferent | 0% | 0/12 |
| Unknown | 0% | 0/12 |
| General | ||
| 8.3% | 1/12 | |
| 16.7% | 2/12 | |
| 41.7% | 5/12 | |
| 33.3% | 4/12 | |
| 25% | 3/12 | |
| 50% | 6/12 | |
| 25% | 3/12 | |
| 25% | 3/12 | |
| 41.7% | 5/12 | |
| 40% | 2/5 | |
| Neurology | ||
| 41.7% | 5/12 | |
| Behavioral problems | 0% | 0/12 |
| 83.3% | 10/12 | |
| Facial abnormalities | ||
| 41.7% | 5/12 | |
| 58.3% | 7/12 | |
| 41.7% | 5/12 | |
| 75% | 9/12 | |
| Visual and hearing impairments | ||
| 8.3% | 1/12 | |
| 25% | 3/12 | |
| Heart | ||
| 33.3% | 4/12 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/12 |
| Gastrointestinal | ||
| 66.7% | 8/12 | |
| Urogenital | ||
| 75% | 9/12 | |
| Skeleton | ||
| 25% | 3/12 | |
| Skin / Hair / Nails | ||
| 25% | 3/12 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/12 |
| Metabolic | 0% | 0/12 |
| Immune | 0% | 0/12 |
| Neoplasia | ||
| Neoplasia | 0% | 0/12 |
| Inheritance | ||
| 100% | 12/12 | |
CENPF